Suppr超能文献

类胡萝卜素与非酒精性脂肪性肝病

Carotenoids and non-alcoholic fatty liver disease.

作者信息

Yilmaz Bahiddin, Sahin Kazim, Bilen Hande, Bahcecioglu Ibrahim H, Bilir Birdal, Ashraf Sara, Halazun Karim J, Kucuk Omer

机构信息

1 Winship Cancer Institute, Emory University, Atlanta, GA, USA ; 2 Division of Animal Nutrition, Faculty of Veterinary Medicine, 3 Division of Gastroenterology, School of Medicine, Firat University, Elazig, Turkey ; 4 Department of Surgery, Emory University, Atlanta, GA, USA.

出版信息

Hepatobiliary Surg Nutr. 2015 Jun;4(3):161-71. doi: 10.3978/j.issn.2304-3881.2015.01.11.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a growing health problem around the world, especially in developed countries. NAFLD includes all cases of fatty liver disease from simple steatosis to cirrhosis, without excessive alcohol intake, use of steatogenic medication or hereditary disorders. Pathogenesis is associated with dietary high fat intake, decreased free fatty acid (FFA) oxidation, increased hepatic lipogenesis and lipolysis from the adipose tissue. These metabolic alterations contribute to the hepatic fat accumulation. Consequently, stimulated oxidative stress and inflammation play a major role in hepatocellular damage. Therefore, antioxidant and anti-inflammatory agents may have a role in the prevention of this disease. Carotenoids are potent antioxidant and anti-inflammatory micronutrients, which have been investigated in the prevention and treatment of NAFLD. The main sources of the carotenoids are fruits and vegetables. In this article we review the potential role and possible molecular mechanism of carotenoids in NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是全球范围内日益严重的健康问题,在发达国家尤为突出。NAFLD包括从单纯性脂肪变性到肝硬化的所有脂肪性肝病病例,且无过量饮酒、使用致脂肪生成药物或遗传性疾病。其发病机制与饮食中高脂肪摄入、游离脂肪酸(FFA)氧化减少、肝脏脂肪生成增加以及脂肪组织的脂肪分解增加有关。这些代谢改变导致肝脏脂肪堆积。因此,由此引发的氧化应激和炎症在肝细胞损伤中起主要作用。所以,抗氧化剂和抗炎剂可能在预防这种疾病中发挥作用。类胡萝卜素是强效的抗氧化和抗炎微量营养素,已被研究用于NAFLD的预防和治疗。类胡萝卜素的主要来源是水果和蔬菜。在本文中,我们综述类胡萝卜素在NAFLD中的潜在作用和可能的分子机制。

相似文献

1
Carotenoids and non-alcoholic fatty liver disease.
Hepatobiliary Surg Nutr. 2015 Jun;4(3):161-71. doi: 10.3978/j.issn.2304-3881.2015.01.11.
2
Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease.
Prev Nutr Food Sci. 2019 Jun;24(2):103-113. doi: 10.3746/pnf.2019.24.2.103. Epub 2019 Jun 30.
5
Non-alcoholic fatty liver disease.
Crit Rev Clin Lab Sci. 2011 May-Jun;48(3):97-113. doi: 10.3109/10408363.2011.596521.
6
Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review.
Antioxidants (Basel). 2019 Jul 19;8(7):229. doi: 10.3390/antiox8070229.
7
Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
Transl Gastroenterol Hepatol. 2020 Oct 5;5:49. doi: 10.21037/tgh.2019.12.05. eCollection 2020.
8
Non-Alcoholic Fatty Liver Disease.
Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.
9
The role of hepassocin in the development of non-alcoholic fatty liver disease.
J Hepatol. 2013 Nov;59(5):1065-72. doi: 10.1016/j.jhep.2013.06.004. Epub 2013 Jun 18.
10

引用本文的文献

2
Multi-Omics Analysis Reveals Causal Relationships and Potential Mediators Between Dietary Preferences and Risk of NAFLD.
Food Sci Nutr. 2025 Jun 23;13(6):e70446. doi: 10.1002/fsn3.70446. eCollection 2025 Jun.
4
Natural allelic variation of basic helix-loop-helix transcription factor 25 regulates carotenoid biosynthesis in sweet potato.
Plant Biotechnol J. 2025 Jul;23(7):2627-2644. doi: 10.1111/pbi.70086. Epub 2025 Apr 10.
7
Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review.
Obes Pillars. 2024 Oct 10;12:100142. doi: 10.1016/j.obpill.2024.100142. eCollection 2024 Dec.
9
Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy.
Front Cell Dev Biol. 2024 Sep 5;12:1444198. doi: 10.3389/fcell.2024.1444198. eCollection 2024.

本文引用的文献

1
Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice.
Cancer Prev Res (Phila). 2014 Dec;7(12):1219-27. doi: 10.1158/1940-6207.CAPR-14-0154. Epub 2014 Oct 7.
3
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.
World J Gastroenterol. 2014 Sep 14;20(34):12082-101. doi: 10.3748/wjg.v20.i34.12082.
6
β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
PLoS One. 2014 May 23;9(5):e98294. doi: 10.1371/journal.pone.0098294. eCollection 2014.
7
Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Mol Nutr Food Res. 2014 Jan;58(1):147-71. doi: 10.1002/mnfr.201300522. Epub 2013 Dec 3.
10
Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis.
J Nutr Biochem. 2013 Nov;24(11):1870-81. doi: 10.1016/j.jnutbio.2013.05.003. Epub 2013 Aug 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验